Skip to main content

Table 2 Distribution of HLA-DRB1 alleles in the study population

From: Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor

  

RA

(n = 235)

Non-RA

(n = 173)

Controls

(n = 269)

SE

*0101

49 (10.4%)

15 (4.3%)

32 (5.9%)

 

*0102

17 (3.6%)

13 (3.7)

16 (3.0%)

 

*0401

27 (5.7%)

10 (2.9%)

23 (4.3%)

 

*0404

19 (4%)

7 (2.0%)

10 (1.8%)

 

*0405

27 (5.7%)

9 (2.6%)

17 (3.1%)

 

*0408

4 (0.8%)

5 (1.4%)

8 (1.5%)

 

*1001

18 (3.8%)

7 (2.0%)

18 (3.3%)

 

*1402

4 (0.8%)

2 (0.6%)

3 (0.5%)

DR3

*03

43 (9.1%)

54 (15.6%)

55 (10.2%)

DERAA

*0103

4 (0.8%)

9 (2.6%)

14 (2.6%)

 

*0402

7 (1.5%)

6 (1.7%)

10 (1.8%)

 

*1102

6 (1.3%)

5 (1.4%)

11 (2.0%)

 

*1103

7 (1.5%)

7 (2.0%)

12 (2.3%)

 

*1301

25 (5.3%)

20 (5.8%)

27 (5.0%)

 

*1302

11 (2.3%)

1 (0.3%)

5 (0.9%)

 

*1304

-

-

-

  1. Percentages relate to number of total alleles.
  2. Data are presented as number and percentage of patients in each group. DERAA, HLA with DERAA-encoding alleles; DR3, HLA-DR3; Non-RA, other arthropathies; RA, rheumatoid arthritis; SE, shared epitope alleles.